Robin E. Offord
Team Member @ Eclosion SA
Robin E. Offord is a startup investor at Eclosion SA. Prof. Robin Offord holds a PhD and a postgraduate degree from Cambridge University, which he gained at the molecular biology laboratory. He worked alongside three Nobel Prize winners, Frederick Sanger, César Milsteinand Dorothy Klug, and lectured at Oxford University for 14 years. He is director of the medical biochemistry department at GenevaUniversity, and was president of its fundamental medicine section. For the past 25 years, Prof. Offord has been a scientific adviser to many large pharmaceutical and biotechnology companies. He has cofounded several startups: GeneProt, whose first president he was; the California-based Ciphergen and the Institut Suisse de Bioinformatique. He currently devotes most of his energy to the Mintaka Foundation, which he founded.
Last updated:
For AI agents: llms.txt
About Eclosion SA
Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up
Eclosion SA Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Benoît Dubois
Team Member
|
|||
|
Emanuela Dose-Sarfatis
Team Member
|
|||
|
Gerard Gandillon
Team Member
|
|||
|
Markus G. Schriber
Team Member
|
|||
|
Robin E. Offord
Team Member
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
